Adding Pluvicto to standard therapy in metastatic patients led to a radiographic PFS benefit, but questions remain about ...

Metformin failed to prevent metabolic syndrome in men on hormonal therapy for prostate cancer but did improve risk factors ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...

Adding the drug enzalutamide to standard hormone therapy reduced the risk of premature death by more than 40% in patients ...

Kids with a rare bone cancer called Ewing sarcoma might live longer if prescribed pazopanib, a drug that blocks blood supply ...

Men with suspected prostate cancer will be able to get a diagnosis on the NHS within a day, under “game-changing” new trials.

Opposition parties at Queen’s Park are renewing calls for the government to cover a simple blood test that helps detect ...

Researchers found that patients who took statins alongside apalutamide and standard hormone therapy had higher three-year ...

Adding the drug enzalutamide to standard hormone therapy reduced deaths by more than 40% in men with recurrent prostate ...

Prostate cancer is one of the most common and serious health issues affecting men worldwide. In its early stages, the ...

The combination of niraparib and abiraterone halves the spread of prostate cancer in men with BRCA gene mutations.